These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16028697)
1. In vivo biopanning: A methodological approach to identifying novel targeting ligands for delivery of biological agents to the vasculature. Work LM; Nicol CG; Denby L; Baker AH Methods Mol Med; 2005; 108():395-413. PubMed ID: 16028697 [TBL] [Abstract][Full Text] [Related]
2. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Reynolds PN; Zinn KR; Gavrilyuk VD; Balyasnikova IV; Rogers BE; Buchsbaum DJ; Wang MH; Miletich DJ; Grizzle WE; Douglas JT; Danilov SM; Curiel DT Mol Ther; 2000 Dec; 2(6):562-78. PubMed ID: 11124057 [TBL] [Abstract][Full Text] [Related]
3. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. Printz MA; Gonzalez AM; Cunningham M; Gu DL; Ong M; Pierce GF; Aukerman SL Hum Gene Ther; 2000 Jan; 11(1):191-204. PubMed ID: 10646650 [TBL] [Abstract][Full Text] [Related]
5. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. Einfeld DA; Schroeder R; Roelvink PW; Lizonova A; King CR; Kovesdi I; Wickham TJ J Virol; 2001 Dec; 75(23):11284-91. PubMed ID: 11689608 [TBL] [Abstract][Full Text] [Related]
6. Cell-selective viral gene delivery vectors for the vasculature. Baker AH; Kritz A; Work LM; Nicklin SA Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621 [TBL] [Abstract][Full Text] [Related]
7. Identification of peptides that target the endothelial cell-specific LOX-1 receptor. White SJ; Nicklin SA; Sawamura T; Baker AH Hypertension; 2001 Feb; 37(2 Pt 2):449-55. PubMed ID: 11230317 [TBL] [Abstract][Full Text] [Related]
8. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Nicklin SA; White SJ; Watkins SJ; Hawkins RE; Baker AH Circulation; 2000 Jul; 102(2):231-7. PubMed ID: 10889136 [TBL] [Abstract][Full Text] [Related]
9. Advances towards targetable adenovirus vectors for gene therapy. Einfeld DA; Roelvink PW Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery. Li J; Lad S; Yang G; Luo Y; Iacobelli-Martinez M; Primus FJ; Reisfeld RA; Li E J Virol; 2006 Dec; 80(24):12324-31. PubMed ID: 17020947 [TBL] [Abstract][Full Text] [Related]
19. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402 [TBL] [Abstract][Full Text] [Related]
20. Gene transfer to cervical cancer with fiber-modified adenoviruses. Rein DT; Breidenbach M; Wu H; Han T; Haviv YS; Wang M; Kirby TO; Kawakami Y; Dall P; Alvarez RD; Curiel DT Int J Cancer; 2004 Sep; 111(5):698-704. PubMed ID: 15252838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]